GenSight Biologics Reveals 5-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy from REFLECT Study GenSight Biologics, a biopharma company dedicated to developing gene therapies for retinal neurodegenerative diseases and…
Ellipses Licenses First-in-Class Novel Immuno-Oncology Agent Ellipses Pharma Limited (“Ellipses”), a global drug development company dedicated to advancing cancer treatments, announced today that it has in-licensed the global rights to…
Glox Therapeutics Appoints Dr. Michael Murray as Chair and Dr. Nel Moore to Scientific Advisory Board Glox Therapeutics, a leader in developing precision antibiotic therapies using naturally occurring bacteriocins, has…
Blackstone Life Sciences and Anthos Therapeutics Reach Deal for Novartis to Acquire Anthos for up to $3.1 Billion Blackstone Life Sciences and Anthos Therapeutics, Inc., a clinical-stage biopharmaceutical company focused…
LIB Therapeutics Announces FDA Acceptance of Lerodalcibep BLA for LDL-C Reduction LIB Therapeutics Inc., a late-stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted…
GeneDx Integrates with Epic to Expand Genome and Exome Sequencing for Faster Diagnosis and Treatment GeneDx (Nasdaq: WGS), a leader in genomic insights for improved health outcomes, announced the launch…
Aurion Biotech Names Donald Munoz as New Chief Financial Officer Aurion Biotech, Inc. (Aurion), a company dedicated to restoring vision for millions through transformative regenerative therapies, announced today the appointment…
AdvanCell Partners with Lilly to Develop Targeted Alpha Therapies for Cancer AdvanCell, a clinical-stage radiopharmaceutical company focused on targeted alpha therapies, today revealed an expansion of its strategic collaboration with…
Satellos Completes Enrollment for Phase 1 SAT-3247 Trial in Healthy Volunteers Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotech company focused on developing small molecule therapies to treat muscle…
Orca-T® Hits Primary Endpoint in Precision-T Phase 3 Study for Hematologic Cancers Orca Bio, a late-stage biotechnology company focused on revolutionizing patient care through advanced cell therapies, today announced it…
Santhera Announces Catherine Isted as New CFO Santhera Pharmaceuticals (SIX: SANN) has announced the appointment of Catherine Isted as the company’s new Chief Financial Officer (CFO), effective February 24, 2025.…
PHC and CCRM Partner to Develop T-Cell Expansion Processes for Enhanced Efficiency and Quality PHC Corporation has entered into a Master Collaboration Agreement with CCRM to develop primary T-cell expansion…